| |
|
Agency for Healthcare Research and Quality (39)
CAHPS Clinician & Group Survey
- Patients' experiences: adult patient's overall rating of their provider (or doctor) on the CAHPS Clinician & Group Adult 12-Month Survey.
- Patients' experiences: adult patients overall rating of their provider (or doctor) on the CAHPS Clinician & Group Adult Visit Survey.
- Patients' experiences: parents/guardians overall rating of their child's provider (or doctor) on the CAHPS Clinician & Group Child Visit Survey.
- Patients' experiences: parents/guardians overall rating of their provider (or doctor) on the CAHPS Clinician & Group Child 12-Month Survey.
- Patients' experiences: percentage of adult patients who reported how often is was easy for them to get appointments and needed care on the CAHPS Clinician & Group Adult 12-Month Survey.
- Patients' experiences: percentage of adult patients who reported how often it was easy for them to get appointments and needed care on the CAHPS Clinician & Group Adult Visit Survey.
- Patients' experiences: percentage of adult patients who reported how often it was easy for them to get appointments and needed care.
- Patients' experiences: percentage of adult patients who reported how often their provider (or doctor) communicated well on the CAHPS Clinician & Group Adult 12-Month Survey.
- Patients' experiences: percentage of adult patients who reported how often their provider discussed medication decisions.
- Patients' experiences: percentage of adult patients who reported how often their provider’s (or doctor’s) office followed up on results for blood tests, x-rays or any other tests ordered on the CAHPS Clinician & Group Adult Visit Survey.
- Patients' experiences: percentage of adult patients who reported how often their provider’s (or doctor) office staff was courteous and helpful on the CAHPS Clinician & Group Adult 12-Month Survey.
- Patients' experiences: percentage of adult patients who reported how often their provider’s office paid attention to care from other providers.
- Patients' experiences: percentage of adult patients who reported how often their provider’s office paid attention to their mental and emotional health.
- Patients' experiences: percentage of adult patients who reported how often their provider’s office supported them in taking care of their health.
- Patients' experiences: percentage of adult patients who reported how often their providers (or doctors) communicated well on the CAHPS Clinician & Group Adult Visit Survey.
- Patients' experiences: percentage of adult patients who reported how often their provider's (or doctor's) staff was courteous and helpful on the CAHPS Clinician & Group Adult Visit Survey.
- Patients' experiences: percentage of adult patients who reported how often their provider's office provided information about care and other appointments.
- Patients' experiences: percentage of adult patients who reported their provider’s office followed up with them about results of a blood test, x-ray, or other test on the CAHPS Clinician & Group Adult 12-Month Survey.
- Patients' experiences: percentage of parents/guardians who reported how often it was easy for them to get appointments and needed care for their child on the CAHPS Clinician & Group Child 12-Month Survey.
- Patients' experiences: percentage of parents/guardians who reported how often it was easy for them to get appointments and needed care for their child on the CAHPS Clinician & Group Child Visit Survey.
- Patients' experiences: percentage of parents/guardians who reported how often it was easy for them to get appointments and needed care for their child.
- Patients' experiences: percentage of parents/guardians who reported how often their child’s provider paid attention to their care from other providers.
- Patients' experiences: percentage of parents/guardians who reported how often their child’s provider’s (or doctor's) office followed up on results for blood tests, x-rays or any other tests ordered on the CAHPS Clinician & Group Child 12-Month Survey.
- Patients' experiences: percentage of parents/guardians who reported how often their child’s provider’s office provided information about care and appointments.
- Patients' experiences: percentage of parents/guardians who reported how often their child’s provider’s office supported them in taking care if their child’s health.
- Patients' experiences: percentage of parents/guardians who reported how often their child's provider (or doctor) communicated well on the CAHPS Clinician & Group Child 12-Month Survey.
- Patients' experiences: percentage of parents/guardians who reported how often their child's provider (or doctor) communicated well on the CAHPS Clinician & Group Child Visit Survey.
- Patients' experiences: percentage of parents/guardians who reported how often their child's provider’s (or doctor’s) office followed up on results for blood tests, x-rays or any other tests ordered on the CAHPS Clinician & Group Child Visit Survey.
- Patients' experiences: percentage of parents/guardians who reported how often their child's provider’s (or doctor’s) office staff was courteous and helpful on the CAHPS Clinician & Group Child 12-Month Survey.
- Patients' experiences: percentage of parents/guardians who reported how often their child's provider’s (or doctor’s) office staff was courteous and helpful on the CAHPS Clinician & Group Child Visit Survey.
- Patients' experiences: percentage of parents/guardians who reported that their child’s provider (or doctor) talked about keeping their child from getting injured, the food the child eats, physical activity, and household problems on the CAHPS Clinician & Group Child 12-Month Survey.
- Patients' experiences: percentage of parents/guardians who reported that their child’s provider (or doctor) talked about keeping their child from getting injured, the food the child eats, physical activity, and household problems on the CAHPS Clinician & Group Child Visit Survey.
- Patients' experiences: percentage of parents/guardians who reported that their child’s provider (or doctor) talked about their child’s growth, behaviors, moods and emotions, and ability to learn and get along with others on the CAHPS Clinician & Group Child 12-Month Survey.
- Patients' experiences: percentage of parents/guardians who reported that their child’s provider (or doctor) talked about their child’s growth, behaviors, moods and emotions, and ability to learn and get along with others on the CAHPS Clinician & Group Child Visit Survey.
CAHPS Nursing Home Survey
- Patients' experiences: family member’s overall rating of their family member’s care.
- Patients' experiences: percentage of family members who reported how often their family member’s nurses/aides were kind and respectful.
- Patients' experiences: percentage of family members who reported how often their family member’s nursing home provided appropriate staffing, care of belongings, and cleanliness.
- Patients' experiences: percentage of family members who reported how often their family member’s nursing home provided information and encouraged respondent involvement.
- Patients' experiences: percentage of family members who reported that their family member’s basic needs were met.
|
|
|
Ambulatory Surgery Center (ASC) Quality Collaboration (6)
Ambulatory Surgery Center (ASC) Quality Measures
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions experiencing a burn prior to discharge.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions experiencing a fall within the confines of the ASC.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions requiring a hospital transfer or hospital admission upon discharge from the ASC.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions who experienced a wrong site, wrong side, wrong patient, wrong procedure, or wrong implant.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions with an order for a prophylactic IV antibiotic for prevention of surgical site infection, who received the prophylactic antibiotic on time.
- Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions with surgical site hair removal with a razor or clippers from the scrotal area, or with clippers or depilatory cream for all other surgical sites.
|
|
|
American College of Surgeons (25)
Melanoma Quality Indicators
- Melanoma: is the surgeon who performs sentinel lymph node biopsy (SLNB) or lymph node dissection (LND) for melanoma certified by the American Board of Surgery or equivalent board or international association?
- Melanoma: percentage of patients newly diagnosed with stage IV melanoma for whom a serum lactate dehydrogenase (LDH) level is measured.
- Melanoma: percentage of patients to undergo a sentinel lymph node biopsy (SLNB) for melanoma for whom lymphoscintigraphy is performed to identify the draining nodal basin(s).
- Melanoma: percentage of patients treated for melanoma for whom stage-specific follow-up, including future skin exams, is discussed and documented.
- Melanoma: percentage of patients who have a resected primary melanoma metastatic to regional lymph nodes or distant sites for whom there is a documented discussion regarding adjuvant therapy.
- Melanoma: percentage of patients who have a stage Ib or II melanoma with whom sentinel lymph node biopsy (SLNB) is discussed.
- Melanoma: percentage of patients who have stages 0, I, or IIA melanoma for whom an abdominal CT/MRI, pelvic CT/MRI, or PET scan was performed, not in response to specific signs or symptoms.
- Melanoma: percentage of patients who undergo a cervical lymph node dissection (LND) or complete lymph node dissection (CLND) for melanoma for whom at least 15 regional lymph nodes are resected and pathologically examined.
- Melanoma: percentage of patients who undergo a sentinel lymph node biopsy (SLNB) for melanoma for whom the sentinel lymph nodes (SLNs) are examined with serial sectioning/hematoxylin and eosin (HE) and with immunohistochemistry (IHC) if the HE analysis is negative or equivocal (i.e., S-100, HMB-45, and MART-1).
- Melanoma: percentage of patients who undergo a sentinel lymph node biopsy (SLNB) for melanoma for whom the sentinel lymph nodes (SLNs) are sent for permanent sectioning only (no frozen sections), unless a reason is documented.
- Melanoma: percentage of patients who undergo a sentinel lymph node biopsy (SLNB) or lymph node dissection (LND) for melanoma for whom the pathology report documents the number of lymph nodes examined and the number of lymph nodes found to contain metastases.
- Melanoma: percentage of patients who undergo an axillary lymph node dissection (LND) or complete lymph node dissection (CLND) for melanoma for whom at least 10 regional lymph nodes are resected and pathologically examined.
- Melanoma: percentage of patients who undergo an inguinal lymph node dissection (LND) or complete lymph node dissection (CLND) for melanoma for whom at least five regional lymph nodes are resected and pathologically examined.
- Melanoma: percentage of patients with a melanoma for whom a clear histologic margin is documented.
- Melanoma: percentage of patients with a melanoma for whom the pathology report documents Breslow thickness, Clark level, histologic ulceration, peripheral/radial and deep margin statuses, satellitosis, anatomic location of the lesion, regression, and mitotic rate.
- Melanoma: percentage of patients with a melanoma for whom the surgeon documented the measured surgical margin in the operative report.
- Melanoma: percentage of patients with a melanoma less than or equal to 1 mm thick (i.e., T1) for whom the surgical excision margins are 1 cm (or the specific anatomic or cosmetic factors that limit margin distance are noted).
- Melanoma: percentage of patients with a melanoma 1-2 mm thick (i.e., T2) for whom the surgical excision margins are 1-2 cm (or the specific anatomic or cosmetic factors that limit margin distance are noted).
- Melanoma: percentage of patients with a melanoma greater than or equal to 2 mm thick (i.e., T3 or T4) for whom the surgical excision margins are 2-3 cm (or the specific anatomic or cosmetic factors that limit margin distance are noted).
- Melanoma: percentage of patients with a melanoma in situ (i.e., Tis) for whom the surgical excision margins are 5 mm (or the specific anatomic or cosmetic factors that limit margin distance are noted).
- Melanoma: percentage of patients with melanoma and clinically apparent/palpable lymphadenopathy for whom a lymph node dissection (LND) was performed without an antecedent histologic diagnosis.
- Melanoma: percentage of patients with melanoma having biopsy-proven or palpable nodal disease and no evidence of distant metastases, who undergo a lymph node dissection (LND).
- Melanoma: percentage of patients with melanoma who have a metastatic lymph node detected on sentinel lymph node biopsy (SLNB) for whom a complete lymph node dissection (CLND) is performed except in the context of a clinical trial or if the patient has severe comorbidities.
- Melanoma: percentage of patients with melanoma who have biopsy-proven, palpable nodal disease, who do not undergo sentinel lymph node biopsy (SLNB).
- Melanoma: percentage of patients with melanoma who have clinically palpable nodal disease of the inguinofemoral nodes for whom a pelvic computed tomography (CT) or positron emission tomography (PET) is obtained to rule out pelvic lymphadenopathy.
|
|
|
American Medical Association (9)
Communication Climate Assessment Toolkit (C-CAT)
- New Communication climate: mean scale score for the “Community Engagement” items on the Patient (or Pediatric) Survey and Staff Survey.
- New Communication climate: mean scale score for the “Data Collection” items on the Patient (or Pediatric) Survey and Staff Survey.
- New Communication climate: mean scale score for the “Health Literacy” items on the Patient (or Pediatric) Survey and Staff Survey.
- New Communication climate: mean scale score for the “Individual Engagement” items on the Patient (or Pediatric) Survey and Staff Survey.
- New Communication climate: mean scale score for the “Language” items on the Patient (or Pediatric) Survey and Staff Survey.
- New Communication climate: mean scale score for the “Leadership Commitment” items on the Patient (or Pediatric) Survey and Staff Survey.
- New Communication climate: mean scale score for the “Performance Evaluation” items on the Patient (or Pediatric) Survey and Staff Survey.
- New Communication climate: mean scale score for the “Socio-Cultural Context” items on the Patient (or Pediatric) Survey and Staff Survey.
- New Communication climate: mean scale score for the “Workforce Development” items on the Patient (or Pediatric) Survey and Staff Survey.
|
|
|
Australian Council on Healthcare Standards (29)
Australian Council on Healthcare Standards (ACHS) Equip Clinical Indicators
- Central line-associated blood stream infection (CLAB) rate: percentage of paediatric intensive care unit (ICU)-associated centrally-inserted central line-associated blood stream infection (CI-CLAB), during the 6 month time period.
- Central line-associated blood stream infection (CLAB): percentage of haematology unit-related centrally-inserted central line-associated blood stream infection (CI-CLAB), during the 6 month time period.
- Central line-associated blood stream infection (CLAB): percentage of haematology unit-related peripherally-inserted central line-associated blood stream infection (PI-CLAB), during the 6 month time period.
- Central line-associated blood stream infection (CLAB): percentage of oncology unit-related centrally-inserted central line-associated blood stream infection (CI-CLAB), during the 6 month time period.
- Central line-associated blood stream infection (CLAB): percentage of oncology unit-related peripherally-inserted central line-associated blood stream infection (PI-CLAB), during the 6 month time period.
- Central line-associated blood stream infection (CLAB): percentage of outpatient intravenous therapy (OPIV) unit-related centrally-inserted central line-associated blood stream infections (CI-CLABs), during the 6 month time period.
- Central line-associated blood stream infection (CLAB): percentage of outpatient intravenous therapy (OPIV) unit-related peripherally-inserted central line-associated blood stream infections (PI-CLABs), during the 6 month time period.
- Central line-associated blood stream infection (CLAB): percentage of paediatric intensive care unit (ICU)-associated peripherally-inserted central line-associated blood stream infection (PI-CLAB), during the 6 month time period.
- Central line-utilisation ratio (CLUR): number of centrally-inserted (CI) central line-days per patient-days in adult intensive care unit (ICU), during the 6 month time period.
- Central line-utilisation ratio (CLUR): number of centrally-inserted (CI) central line-days per patient-days in paediatric intensive care unit (ICU), during the 6 month time period.
- Central line-utilisation ratio (CLUR): number of peripherally-inserted (PI) central line-days per patient-days in adult intensive care unit (ICU), during the 6 month time period.
- Central line-utilisation ratio (CLUR): number of peripherally-inserted (PI) central line-days per patient-days in paediatric intensive care unit (ICU), during the 6 month time period.
- Haemodialysis-associated blood stream infection: percentage of AV-fistula access-associated blood stream infections, during the 6 month time period.
- Haemodialysis-associated blood stream infection: percentage of centrally inserted cuffed line access-associated blood stream infections, during the 6 month time period.
- Haemodialysis-associated blood stream infection: percentage of centrally inserted non-cuffed line access-associated blood stream infections, during the 6 month time period.
- Haemodialysis-associated blood stream infection: percentage of native vessel graft access-associated blood stream infections, during the 6 month time period.
- Haemodialysis-associated blood stream infection: percentage of synthetic graft access-associated blood stream infections, during the 6 month time period.
- Healthcare-associated MRSA: percentage of intensive care unit (ICU)-associated new methicillin-resistant Staphylococcus aureus (MRSA) healthcare-associated infections in a non-sterile site, during the 6 month time period.
- Healthcare-associated MRSA: percentage of intensive care unit (ICU)-associated new methicillin-resistant Staphylococcus aureus (MRSA) healthcare-associated infections in a sterile site, during the 6 month time period.
- Healthcare-associated MRSA: percentage of non-intensive care unit (ICU)-associated new methicillin-resistant Staphylococcus aureus (MRSA) healthcare-associated infections in a non-sterile site, during the 6 month time period.
- Healthcare-associated MRSA: percentage of non-intensive care unit (ICU)-associated new methicillin-resistant Staphylococcus aureus (MRSA) inpatient healthcare-associated infections in a sterile site, during the 6 month time period.
- Neonatal infections: percentage of babies of birth weight less than 1000 grams admitted to the neonatal intensive care unit (NICU) during the time period under study who have a significant blood infection occurring more than 48 hours after birth at any time during their whole admission.
- Neonatal infections: percentage of babies of greater than or equal to 1000 grams birth weight, admitted to the neonatal intensive care unit (NICU) during the time period under study who have a significant blood infection occurring more than 48 hours after birth at any time during their whole admission.
- Neonatal infections: percentage of live babies born at the reporting hospital who develop blood stream and/or cerebrospinal fluid (CSF) infection within 48 hours of birth and who were born in the 6 month time period.
- Neonatal infections: percentage of live babies of greater than or equal to 37 weeks estimated gestational age at birth (GA) born at the reporting hospital who develop a blood and/or cerebrospinal fluid (CSF) infection within 48 hours of birth and who were born in the 6 month time period.
- Neonatal infections: percentage of significant blood infections in neonatal intensive care unit (NICU) admitted babies of greater than or equal to 1000 grams birth weight, occurring more than 48 hours of birth, during the 6 month time period.
- Neonatal infections: percentage of significant blood infections in neonatal intensive care unit (NICU) admitted babies of less than 1000 grams birth weight, occurring more than 48 hours of birth, during the 6 month time period.
- Occupational exposure: percentage of reported non-parenteral exposures sustained by staff, during the 6 month time period.
- Occupational exposure: percentage of reported parenteral exposures sustained by staff, during the 6 month time period.
|
|
|
